Tirbanibulin

From WikiMD.org
Jump to navigation Jump to search

Tirbanibulin

Tirbanibulin (pronounced as tee-r-ba-ni-byoo-lin) is a small molecule inhibitor that is used in the treatment of various types of cancer. It is also known by its trade name, Klisyri.

Etymology

The name "Tirbanibulin" is derived from the chemical structure of the drug. The prefix "Tir-" is derived from the chemical name "tubulin inhibitor", which describes the drug's mechanism of action. The suffix "-bulin" is a common suffix used in the names of drugs that inhibit tubulin, a protein involved in cell division.

Mechanism of Action

Tirbanibulin works by inhibiting the polymerization of tubulin, a protein that forms the microtubules necessary for cell division. By preventing the formation of these microtubules, tirbanibulin stops cancer cells from dividing and growing.

Uses

Tirbanibulin is used in the treatment of actinic keratosis, a skin condition that can lead to skin cancer. It is also being studied for use in the treatment of other types of cancer, including non-small cell lung cancer and bladder cancer.

Side Effects

Common side effects of tirbanibulin include skin irritation, redness, and swelling at the application site. More serious side effects can include allergic reactions and changes in skin color.

Related Terms

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski